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MaCoronary artery bypass grafting is the most common cardiac surgery operation performed worldwide. It is the most
effective revascularization method for several categories of patients affected by coronary artery disease. Although cor-
onary artery bypass grafting has been performed for more than 40 years, no detailed guidelines on the choice of coronary
artery bypass grafting conduits have been published and the choice of the revascularization strategy remains more a
matter of art than of science. Moreover, there is a clear contradiction between the proven beneﬁts of arterial grafting and
its very limited use in everyday clinical practice. In the hope of encouraging wider diffusion of arterial revascularization
and to provide a guide for clinicians, we discuss current evidence for the use of different conduits in coronary artery
bypass surgery and propose an evidence-based algorithm for the choice of the second conduit during coronary artery
bypass operations. (J Am Coll Cardiol 2015;66:1729–37) © 2015 by the American College of Cardiology Foundation.A lthough coronary artery bypass graft (CABG)has been performed for more than 40 years,no detailed guidelines on the choice of
CABG conduits have been published to date. More-
over, current practice demonstrates a clear contradic-
tion between the proven beneﬁts of arterial grafting
and the very limited use of arterial conduits in
everyday clinical practice.
With the aim of encouraging a wider diffusion of
arterial revascularization, and to provide a guide for
clinicians,weherein discuss the current evidence basis
for the use of different arterial conduits for CABG and
propose an evidence-based algorithm for the choice
of the second conduit during coronary operations.
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scripts. References for all selected studies were cross-
checked. The present review focuses on data from
randomized controlled trials (RCT), propensity-
matched observational series, and meta-analyses.
Unmatched observational series were considered
only when data from RCT or propensity-matched
studies were not available.
It is important to note that the quality and weight
of the evidence for the various conduits is not
the same. RCT and propensity-matched series
include around 25,000 patients for bilateral internal
thoracic arteries (BITA), 2,000 for the radial artery
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ABBR EV I A T I ON S
AND ACRONYMS
BITA = bilateral internal
thoracic artery
CABG = coronary artery bypass
graft
CI = conﬁdence interval
GEA = gastroepiploic artery
HR = hazard ratio
ITA = internal thoracic artery
LAD = left anterior descending
OR = odds ratio
RA = radial artery
RCT = randomized controlled
trial(s)
RITA = right internal thoracic
artery
RR = relative risk
SVG = saphenous vein graft(s)
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1730BILATERAL INTERNAL
THORACIC ARTERIES
The survival beneﬁts associated with the use
of the left internal thoracic artery (ITA) to
the left anterior descending (LAD) coronary
artery were established in a landmark paper
from the Cleveland Clinic almost 30 years
ago (1). The improved outcome using the ITA
is almost certainly due to its superior long-
term patency. Several studies have reported
substantially inferior patency rates with
saphenous vein grafts (SVG), of which
approximately 75% are occluded or signiﬁ-
cantly diseased at 10 years (2), in comparison
to patency rates in excess of 90% for the ITA
(3). Its peculiar morphologic features prob-
ably explain the superior patency of the ITA.
The ITA has a discontinuous internal elastic
lamina and a relatively thin media withmultiple elastic laminae and the absence of a signiﬁ-
cant muscular component, which explains its reduced
tendency for spasm and the development of athero-
sclerosis (4). Moreover, compared with all other
arterial and venous conduits, it shows increased
production of anti-inﬂammatory and vasoactive
molecules, particularly nitric oxide (4).
The highest patency rates have been documented
when the ITA (either in situ or as a Y or free graft) is
placed to the left-sided coronary vessels (3). Inferior
rates have been documented when the ITA is placed
to the right coronary artery (probably due to size
discrepancy and progression of disease at the crux, or
to a lower amount of viable myocardium) (3).
Only 1 published RCT has compared outcomes
between single ITA and BITA grafting. The ART (Arte-
rial Revascularization Trial) recruited 3,108 patients in
7 countries. The primary outcome is 10-year survival,
but an interim analysis at 1 year (a “safety” endpoint)
reported excellent outcomes with both strategies.
Mortality, stroke, myocardial infarction, and repeat
revascularization were all under 2.5% (5).
While awaiting the outcome of the ART trial, there
is currently a substantial body of circumstantial evi-
dence to support the use of a second ITA, as it appears
to offer an additional survival beneﬁt over a single
ITA graft. Indeed, more than a decade ago, a sys-
tematic review of matched cohorts of almost 15,000
CABG patients who received BITA grafts reported a
signiﬁcant reduction in the hazard ratio (HR) for
mortality of 0.78 (6). In the past 2 years, 2 indepen-
dent meta-analyses have supported this ﬁnding,
not only in larger cohorts of patients, but also withlonger-term follow-up. One study included 27 obser-
vational reports with over 79,000 patients (approxi-
mately one-quarter with BITA), and reported a
signiﬁcant reduction in long-term mortality with
BITA (HR: 0.78; 95% conﬁdence interval [CI]: 0.72 to
0.84; p < 0.00001) (7). Another study included 9
observational series of over 15,000 patients (approx-
imately one-half with BITA), with follow-up duration
exceeding a mean of 9 years, and reported a signiﬁ-
cant reduction in mortality with BITA (HR: 0.79;
95% CI: 0.75 to 0.84) (8). Importantly, no study has
reported any detrimental effect of BITA on survival.
The major concern with the use of BITA grafts is
the increased risk of sternal wound complications and
mediastinitis. One of the largest meta-analysis on this
issue showed that adding a second ITA to the ITA-
LAD graft signiﬁcantly increase the incidence of
sternal complications (relative risk [RR] of a single
ITA: 0.62; 95% CI: 0.55 to 0.71) (9). This risk is even
higher in diabetics and in patients with pulmonary
disease (9). In ART, the incidence of sternal wound
complications increased from 0.6% in the single ITA
group to 1.9% in the BITA group (i.e., an absolute
difference of 1.3% or a number needed to harm of
78 patients) (5).
However, the incidence of serious wound problems
can be signiﬁcantly reduced by judicious patient
selection and the choice of harvesting technique.
Consideration should be given to avoiding BITA
in patients with certain potentially morbid charac-
teristics, especially if they occur simultaneously
(diabetes, obesity, respiratory problems), and in
patients receiving steroids or immunosuppression
treatments. Moreover, 2 systematic reviews have
both reported that skeletonization, rather than a
pedicled harvesting technique, signiﬁcantly reduces
deep sternal wound infections, even in patients with
diabetes (9,10). Importantly, the survival beneﬁt of
BITA grafting is seen in both nondiabetic and diabetic
patients (11).
THE RADIAL ARTERY
Introduced in coronary surgery in the 1970s (12), the
RA was “rediscovered” in the early 1990s (13). Con-
cerns over vasospasm, due to the muscular nature of
the RA wall, have been reduced after the demon-
stration of progressive morphofunctional remodeling
of the artery toward an elastomuscular proﬁle after
implantation in the coronary circulation (14). This
ﬁnding is probably the anatomic background for the
demonstrated lack of utility of long-term antispastic
therapy in patients with RA grafts (15), even though
TABLE 1 RCT Comparing the RA With Other Conduits
First Author or
StudyAcronym
(Ref. #)
Number of
Patients/
Grafts
Mean
Follow-Up
(yrs)
Conduits
Compared
With the RA Main Findings
Goldman et al.
(21)
757 1 SVG No difference in patency
RSVP
(22)
142 5 SVG Better patency for the RA (p ¼ 0.004)
RAPS
(18)
561 7.7 SVG Better patency for the RA (p ¼ 0.002)
Tendency to lower incidence of
adverse clinical events for the RA
RAPCO
(23)
649 6 SVG and
RITA
No difference in patency and clinical
outcome between RA, RITA, SVG
Tendency to lower reintervention on
target vessel for RA vs. SVG and
better event-free survival
for RA vs. RITA
RA ¼ radial artery; RAPCO ¼ Radial Artery Patency and Clinical Outcomes; RAPS ¼ Radial Artery Patency Study;
RITA ¼ right internal thoracic artery; RSVP ¼ Radial Artery Versus Saphenous Vein Patency; SVG ¼ saphenous
vein graft.
TABLE 2 Meta-Analysis Comparing the RA With Other Conduits
First Author
(Ref. #)
Number of
Patients/
Grafts
Mean
Follow-Up
(yrs)
Conduits
Compared
With the RA Main Findings
Benedetto
et al. (24)
936 1.8 SVG No difference in patency
Hu and Zhao
(25)
3,889 1-6 SVG and
RITA
Better patency and reduced wound
complication for RA vs. SVG (p < 0.05)
Comparable survival and patency for
RA and RITA, reduced cardiac events
for RA vs. RITA (p ¼ 0.014).
Athanasiou
et al. (26)
1,157 >5 SVG Better patency for the RA (p ¼ 0.003)
Cao et al. (27) 1,708 >4 SVG Better patency for the RA (p ¼ 0.0001)
Zhang
et al. (28)
1,860 1-7.7 SVG Better patency and lower need for repeat
coronary procedures for RA vs. SVG
(p ¼ 0.0002 and 0.0008 respectively)
Benedetto
et al. (29)
2,780 1-7.7 SVG and
RITA
SVG associated with a 2-fold increased risk
of complete graft occlusion vs. RA after
4 yrs (OR: 2.64; 95% CI: 1.60–4.35)
No difference in patency between
RA and RITA.
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1.
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1731such therapy is still widely adopted in the surgical
community (16).
The largest angiographic series report an RA
patency rate of 80% to 90% at 7 to 10 years follow-up
(17). The severity of the stenosis of the target vessel is
a key factor in determining RA patency. There is
general agreement that the RA should be used only
to bypass a vessel with >70% stenosis, and there is
evidence that a 90% stenosis limit ensures an even
better RA patency rate, especially on the right coro-
nary system (18,19). The site of proximal anastomosis
and the harvesting technique (open vs. endoscopic)
do not affect RA patency rates, whereas there is some
evidence that skeletonization of the artery can lead to
better perfect patency rates (20).
The RA is the arterial conduit for which there is the
most evidence derived from RCT. In fact, 4 RCT have
compared the RA with either SVG or the right internal
thoracic artery (RITA) (18,21–23) (Table 1). All studies
that extended the follow-up beyond the ﬁrst post-
operative year showed signiﬁcantly better patency
rates for the RA over the SVG, and in 2 studies, a
tendency toward a lower incidence of clinical events
was also found for RA patients.
A number of meta-analyses pooled data from these
RCT and large observational studies to compare the
RA and the SVG (24–29). Again, all studies with a
mean follow-up time extending beyond the ﬁrst
postoperative year reported signiﬁcant beneﬁts in
terms of graft patency for the RA (Table 2). The only
meta-analysis to include clinical outcomes found
reduced cardiac death, myocardial infarction, and
repeat coronary procedures, in addition to better late
graft patency for the RA (odds ratio [OR]: 0.72, 0.68,
0.27, and 0.52, respectively) (28).
Only 1 RCT compared the RA and the RITA: the
RAPCO (Radial Artery Patency and Clinical Outcomes)
trial found no difference in the patency of the 2
conduits and a nonsigniﬁcant tendency to better
event-free survival for the RA at the 6-year follow-up
(Table 1) (23). Observational studies addressing this
are discordant and usually have major methodolog-
ical or sample-size limitations (Table 3) (30–33). The
only comparative meta-analysis with clinical end-
points reported comparable mortality, but reduced
cardiac events (myocardial infarction, heart failure,
ischemia) for the RA (RR: 0.49; 95% CI: 0.28 to 0.87;
p ¼ 0.014) (25). Furthermore, a comparative network
meta-analysis of angiographic studies showed that
the RITA was associated with a nonsigniﬁcant 27%
absolute risk reduction for late functional graft
occlusion when compared with the RA (29).
Compared with the RITA, the RA seems a better
choice in patients at risk for post-operative sternalcomplications (diabetes, obesity, chronic pulmonary
disease). Indeed, harvesting of the RA is extremely
safe and well tolerated, even by complex and fragile
patients (25) and (unlike the RITA) does not affect
sternal vascularization and healing. Two recent
propensity-matched comparisons of patients at risk
of sternal complications who received the RA or RITA
as the second conduit reported clear clinical beneﬁts
with use of the RA (31,34). Furthermore, a recent
substudy of the RAPS (Radial Artery Patency Study)
focusing only on diabetic patients reported a very
strong protective effect against graft occlusion with
use of the RA (35), making the use of this conduit
in diabetics particularly attractive. Very limited
TABLE 3 Observational Studies Comparing the Different Arterial Conduits
First Author
(Ref. #) n
Conduits
Compared
Mean
Follow-Up Main Findings
Caputo
et al. (30)
661 RA vs. RITA 18 months Better survival (HR: 0.25) and
event-free survival
(HR: 0.37) for the RA
Tranbaugh
et al. (31)
1,056 RA vs. RITA 9 yrs Better survival and
event-free survival for
the RA (see text)
Ruttmann
et al. (32)
554 RA vs. RITA 57 months Better survival (HR: 0.23) and
event-free survival
(HR: 0.18) for the RITA
Raja et al. (33) 1,020 RA vs. RITA 8 yrs Higher rate of late death (HR: 1.9)
and repeat revascularization
(HR: 1.5) for the RA
Hirose
et al. (36)
197 RA vs. GEA 2.3 yrs Comparable operative mortality
and freedom from
cardiac event
Di Mauro
et al. (37)
295 RA vs. GEA 131 months Comparable early and late
survival and event-free
survival
Pevni
et al. (50)
477 GEA vs. RITA 67 months Comparable survival and
event-free survival
Hwang
et al. (51)
210 GEA vs. RITA 5 yrs Comparable clinical outcome
and patency rate
GEA ¼ gastroepiploic artery; HR ¼ hazard ratio; other abbreviations as in Table 1.
Gaudino et al. J A C C V O L . 6 6 , N O . 1 5 , 2 0 1 5
Choice of Conduits for CABG O C T O B E R 1 3 , 2 0 1 5 : 1 7 2 9 – 3 7
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between the RA and the GEA (Table 3) (36,37).
RIGHT GASTROEPIPLOIC ARTERY
Pym et al. (38) and Suma et al. (39) ﬁrst indepen-
dently reported systematic use of the GEA graft for
CABG in 1987. Since then, GEA grafts have been
widely applied in clinical practice. Very few CABGFIGURE 1 Comparison of Cumulative Patency Rates for GEA Grafts A
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The increased patency rate in case of skeletonized grafts and suboccluscandidates have contraindications to GEA harvesting
(40); the conduit has a low incidence of severe
atherosclerosis (41) and good ﬂow capacity (42). The
biological and physiological proﬁle of the GEA
has now been extensively studied (43), and the use of
this artery does not increase perioperative risk (44).
The most favorable target for the in situ GEA graft is
the distal right coronary artery, but the conduit can
be used also for the distal circumﬂex system. A sub-
occlusive (>90%) stenosis of the target coronary artery
is essential to maximize patency rates and avoid
spasm and eventual failure due to chronic competitive
coronary ﬂow. This concern is formally recognized in
the 2011 ACCF/AHA Guideline for Coronary Artery
Bypass, in which arterial grafting of the RCA is con-
traindicated (Class III, Harm) in patients with less than
critical (i.e., >90%) stenosis of the native vessel (45).
In 1 of the largest GEA series published to date, the
cumulative patency rate of the artery was 97.1% at
1 month, 92.3% at 1 year, 85.5% at 5 years, 80.9% at
7 years, and 66.5% at 10 years after surgery (46). This
relatively low patency rate at late periods has
improved by using a skeletonized GEA graft only to
target vessels with >90% stenosis. Using this
approach, Suzuki et al. (47) have reported 97.8%,
94.7%, and 90.2% cumulative patency rates in the
early post-operative period and at 5 and 8 years after
surgery, respectively (Figure 1).
Two recent series reported that use of the GEA,
instead of the SV, to graft the right coronary artery in
patients having BITA to the left coronary system leads
to a signiﬁcant increase in late survival (48,49).ccording to Skeletonization and Target Selection
60 72 84 96 108 120
ative Months
65 15
ithout target selection (Suma [44])
78 24
5.5
66.5
90.2
4.7
ive target vessel stenosis is evident. GEA ¼ gastroepiploic artery.
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1733However, other studies have not conﬁrmed this
ﬁnding, and a recent network meta-analysis of RCT
comparing all conduits used in coronary surgery
found the GEA to be associated with the highest risk
of functional and complete graft occlusion (29). Of
note, a major bias in the current literature is that the
majority of published series report use of the GEA as a
pedicled, rather than as a skeletonized graft; skele-
tonized harvest of the artery has been shown to
signiﬁcantly improve its patency (47). Very few
studies have compared the GEA with the RITA
(Table 3) (50–52).
COMMENTS
CABG is the most common cardiac surgery operation
performed worldwide. It has been shown to be the
most effective revascularization method for several
categories of patients affected by coronary artery
disease. Long-term conduit patency is the key factor
for the success of the procedure (2). Yet, to date, no
precise guidelines on graft selection exist, and the
choice of revascularization strategy remains more a
matter of art than of science. Although several arterialCENTRAL ILLUSTRATION The Choice of Conduits for CAB
RA
LITA
GSV
Gaudino, M. et al. J Am Coll Cardiol. 2015; 66(15):1729–37.
Possible graft conﬁgurations using multiple arterial conduits. CABG ¼ c
vein; LITA ¼ left internal thoracic artery; RA ¼ radial artery; RGA ¼ righand venous conduits have been proposed during the
last 5 decades, only 4 have stood the test of time: the
ITA, the RA, the GEA, and the great saphenous vein.
Currently, the clinical beneﬁts of using the left ITA
to bypass the LAD artery are well established, and this
graft represents the cornerstone of modern coronary
artery surgery. Robust evidence suggests that the use
of an artery, rather than a vein, to graft to the second
target vessel is associated with further improvement
in late outcome (6–8,53). The beneﬁts of a second
arterial graft apply also to high-risk patients, such as
those with reduced ventricular function or unstable
angina (54,55), and become evident within the ﬁrst
post-operative decade (although the survival advan-
tage tends to increase with time) (53,56). The location
of the second arterial conduit and the use of
sequential technique do not modify the extent of the
survival advantage (57,58).
In sharp contrast with these data, there is evident
reluctance toward a wider adoption of an arterial
revascularization strategy in the surgical community.
A recent analysis of the STS (Society of Thoracic
Surgeons) database showed that, in the United States,
slightly more than 5% of CABG cases receive a secondG: Modern Coronary Artery Surgery
RITA
RGA
LITA
oronary artery bypass graft; GEA ¼ gastroepiploic artery; GSV ¼ great saphenous
t gastroepiploic artery; RITA ¼ right internal thoracic artery.
FIGURE
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diabetes
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1734arterial conduit (59). A similar situation exists both in
Europe and in Asia. In the mostly European SYNTAX
(Synergy Between Percutaneous Coronary Interven-
tion With Taxus and Cardiac Surgery) trial (60), a
second arterial graft was used in 26.2% of patients
in the registry and in 35.3% in the randomized trial
and the rate of BIMA utilization in a 2009 report of
the Australasian Society of Cardiac Surgery was
12.6% (61).
The reasons for this low use of arterial grafts are
complex and multifactorial. More than a decade ago,
a survey among U.K. surgeons reported that the low
use of BITA grafts was because of the perceived con-
cerns of increased technical difﬁculty and enhanced
risk of post-operative complications (62). These con-
cerns are heightened by the trend toward employ-
ment of surgeons by hospitals and hospital networks.
In this scenario, short-term “quality metrics,”
including avoidance of deep sternal wound infection,
may be drivers of surgical decision making because
they directly affect the ﬁnancial status of the
employer institutions (presently, the cost of treat-
ment of sternal complications after CABG is not
reimbursed by U.S. Medicare/Medicaid, as they have2 Algorithm for Graft Selection for the Second Target Vessel in Elective C
Elective CABG candidate with no contrain
No major risk factors for postoperative mediastinitis†
Target vessel stenosis >70% Target vessel stenosis ≤70%
l wall Inferior wall Lateral wall Inferior wall
70–90% stenosis
>90% stenosis
/RA
SVG
RA/GEA
ITA SVG
ite and elongated grafts are not considered. *In the case of contraindications
, and severe chronic lung disease, especially in combination. CABG ¼ corona
artery; RA ¼ radial artery; SVG ¼ saphenous vein graft.been designated “never events” by the U.S. Center for
Medicare & Medicaid Services).
However, the ART trial showed that the use of a
second ITA graft did not increase mortality or other
major morbidity, with the exception of sternal wound
complications, and added only 23 min to the duration
of surgery, in comparison with the use of a single
ITA graft (5). Moreover, the use of the RA, instead
of the RITA, eliminates the risk of mediastinitis
from the equation and can safely extend the use of a
second arterial conduit to the considerable number
of patients at risk of respiratory or sternal wound
complications (31,34). Yet, the RA is used in not more
than 12% of all CABG procedures worldwide (59,60).
The evidence presented earlier indicates that
modern coronary artery surgery should entail the use
of multiple arterial grafts, at least in the absence of
major clinical or anatomic contraindications, and
substantial efforts should be made to increase the
adoption of arterial conduits during CABG procedures
(Central Illustration). The RA and RITA should be
considered similar alternatives for the anterolateral
wall; the RA should be preferred in cases at risk
for sternal complications and the RITA in patientsABG Patients Without Contraindications to RA and GEA Harvesting
dication to RA or GEA harvesting*
Major risk factors for postoperative mediastinitis†
Target vessel stenosis >70% Target vessel stenosis ≤70%
Lateral wall Inferior wall
70–90% stenosis
>90% stenosis
RA SVG
RA/GEA
SVG
to RA or GEA harvesting, SVG should be used. †Deﬁned as: obesity,
ry artery bypass graft; GEA ¼ gastroepiploic artery; ITA ¼ internal
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1735without ulnar compensation. Due to its superior
diameter and length, the RA permits the performance
of sequential anastomoses and is able to reach
even very distal vessels; however, it requires a sub-
occlusive target stenosis. RITA is probably less sen-
sitive to competitive coronary ﬂow and more
appropriate in case of less severe coronary stenosis.
The skeletonized in situ GEA can be considered to
graft to the distal branches of the right coronary
artery when critically stenosed (>90%). The use of
the great saphenous vein should be limited only to
cases in which an arterial conduit is not indicated for
clinical or technical reasons.
On the basis of the evidence reviewed in this study,
we propose an algorithm for the choice of the second
conduit in stable CABG candidates without contrain-
dications to RA or GEA harvesting (Figure 2). In this
algorithm, we have taken into account the most
important technical, anatomic, and angiographic
determinants of arterial conduit patency, as well as
the clinical characteristics of the patient. Due to the
major impact on post-operative mortality, special
relevance has been given to minimization of the risk
of post-operative mediastinitis. In view of its strong
inﬂuence on graft outcome, the severity of targetvessel stenosis (in relation to its location) has been
the other determinant of our tree’s branch points.
As arterial grafts are live conduits and tend to react
much more than venous grafts to native competitive
ﬂow, a functional characterization of the target vessel
lesion is of paramount importance when using an
arterial revascularization strategy. In the future, the
use of fractional ﬂow reserve to plan the conduit’s
conﬁguration, instead of angiography, will allow a
more physiological integration of graft and coronary
ﬂow and is likely to result in enhanced long-term
patency and clinical outcomes.
Less art, more science.
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